SEARCH · Search PubMed
Results for “PSYLLIUM”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
[Probiotics and prebiotics for the treatment of inflammatory bowel disease].
Although the causes of inflammatory bowel disease including ulcerative colitis and Crohn's disease remain incompletely understood, increasing evidence implicates intestinal microflora in the pathogenesis of this disorder. Therefore, modulation of microflora with probiotics or prebiotics may offer a plausible therapeutic approach. While recent data support a potential therapeutic efficacy, such treatments need to be further assessed by large scale studies. A better understanding of the intestinal microflora and the mechanisms of their action may help us to develop more effective treatment for inflammatory bowel disease.
To lower your LDL further, add fiber.
Explore the source record for details and available documents.
Dietary fibre and renal failure: comparison of sterculia and ispaghula.
Explore the source record for details and available documents.
A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
OBJECTIVE To compare the efficacy and acceptability of mebeverine and high-fibre dietary advice versus mebeverine and ispaghula in fixed combination in the treatment of irritable bowel syndrome in adults. DESIGN Open, prospectively randomised, parallel group comparison of mebeverine/dietary advice and mebeverine/ispaghula during an eight-week study period. SETTING General practices in the UK. PATIENTS One hundred and eleven patients with irritable bowel syndrome diagnosed by symptom profile or negative investigations between the ages of 18 and 75 years were entered. All patients had a history of abdominal pain occurring at least once a week for a period of three months or more. INTERVENTION Dosage was 135 mg of mebeverine hydrochloride, three times daily before meals, together with advice on high-fibre dietary intake, or 135 mg of mebeverine hydrochloride plus 3.5 g of ispaghula husk twice or three times daily before meals. MEASUREMENTS AND RESULTS Details of abdominal pain severity and frequency, bowel frequency and stool consistency were recorded by means of clinicians' assessments and patient diaries. Pre-treatment assessments revealed no significant differences between the two groups with respect to any of the parameters. Both treatment groups demonstrated highly significant improvements in the numbers of pain attacks and their severity; no statistically significant differences between the two groups were demonstrated. Five patients in the mebeverine/dietary advice group reported five concurrent effects and nine patients in the mebeverine/ispaghula group reported 13 concurrent effects. All of the mebeverine/dietary advice group found their treatment acceptable but up to 28% of the mebeverine/ispaghula group found their treatment unpalatable. CONCLUSION Both treatments are effective in the treatment of irritable bowel syndrome in adults. The fixed combination of mebeverine/ispaghula, however, was found to be unpalatable by up to 28% of the patients in that group. There does not, therefore, appear to be any advantage in using fixed combination therapy in this condition.
[Monitoring the seeds of chronically irradiated indigenous populations of Plantago lanceolata L. Variability in the progeny].
The results of the morphometric study of Plantago lanceolata L. grown, in nursery, from seeds of the first and second post-accident reproductions within the thirty-kilometer zone around the crippled Chernobyl reactor show no relationship between the alterations in some quantitative indices and the variability of gamma-radiation background in places where maternal plants grow.
Irritable bowel syndrome: clinical presentations, enema users and dosage schedules of Ispaghula.
Explore the source record for details and available documents.
Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial.
To examine the long-term management of irritable bowel syndrome we conducted a two-part controlled therapeutic trial on 28 patients who had recovered completely after four to six weeks of treatment with ispaghula husk and propantheline. In part I patients were randomly divided into two groups. Group A received a placebo capsule while Group B continued with treatment as before. After six months the response to treatment was assessed according to a scoring system. The overall relapse rate in Group B was 46 per cent compared to 82 per cent in group A. With continued treatment patients in Group B became asymptomatic from the fourth month while patients in Group A continued to deteriorate. In part II, patients who had relapsed whilst on placebo received active treatment. Six of the seven who agreed to continue with the study became asymptomatic within four weeks. However, all the patients who were asymptomatic while on active treatment relapsed on discontinuation and again recovered on reinstitution of active treatment. We conclude that irritable bowel syndrome is a chronic relapsing disorder and that treatment with a combination of ispaghula husk and propantheline is effective, both in relieving symptoms and in the maintenance of remission.
Laxatives and cathartics. Uses and abuses.
Explore the source record for details and available documents.
Effect of cellulose & ispaghula on intestinal function of hamsters maintained on diets of varying fibre content.
Explore the source record for details and available documents.
Effect of cellulose and ispaghula husk on fasting blood glucose of developing rats.
Fasting blood sugar was measured at the beginning and end of a 4-wk dietary period during which weanling rats were fed either a fibre-free diet, or a similar diet containing cellulose or ispaghula husk. The fibre-free group showed no significant change, but the groups fed cellulose or ispaghula showed a significant fall in fasting blood sugar.
[Evaluation of the efficacy of the dispensary treatment of patients with chronic esophageal diseases (based on the data from a 10-year dynamic observation)].
The results of follow-up of 460 cases of different chronic esophageal pathologies within 10 years (1975-1984) were analysed. It was established that pathologic processes unceasingly progress to cancer development in cases untreated for subjective or objective reasons. Methyluracil and plantaglucide treatment proved effective.
Management of irritable bowel syndrome.
Few drugs are of proven efficacy in irritable bowel syndrome. Bulking agents probably relieve constipation, spasmolytics may alleviate pain and antidiarrhoeals help control urgency and diarrhoea. With a combination of reassurance and therapeutic intervention up to 75% of patients can be expected to improve. For the 25% who do not, alternative therapies such as stress management, psychotherapy or hypnotherapy may prove effective.
Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients.
The present randomized study compared the influence of a gel-forming wheat bran with a nongel-forming bulk cathartic (an ispaghula formulation, Vi-Siblin S) on the steady state concentrations of digoxin in plasma in 30 geriatric in-patients treated with either combination (16 with wheat bran + digoxin, 14 with ispaghula + digoxin) for 4 weeks. After 2 but not after 4 weeks, wheat bran reduced the digoxin levels, although the levels were still within the therapeutic range. Ispaghula had no influence at any time. It is concluded that neither wheat bran nor the ispaghula formulation has any clinically relevant influence on therapeutic digoxin levels in geriatric patients.
Effect of cellulose & ispaghula husk on small intestinal structure of young rats & hamsters.
Explore the source record for details and available documents.